Biografija

Odbranjena doktorska disertacija 13.04.2013. pod nazivom: “Značaj određivanja mikrosatelitne nestabilnosti kao genetskog markera u kolorektalnom karcinomu”, Medicinski fakultet Univerziteta u Beogradu. Uža naučna oblast molekularna medicina.

Članovi komisije: Prof. Dr Svetozar Damjanović, Prof. Dr Zorica Stojšić, Prof. Dr Njegica Jojić
Mentor: Prof. Dr Zoran Krivokapić, Komentor: Prof. Dr Svetislav Tatić

Specijalizacija Interne medicine 2010-2014, specijalistički ispit iz oblasti interne medicine položio 2014. godine sa odličnim uspehom (Univerzitet u Beogradu, Medicinski fakultet).

Rad uže specijalizacije pod nazivom: “Optimizacija biološke terapije kod pacijenata sa inflamatornim bolestima creva“, Medicinski fakultet Univerziteta u Beogradu, odbranio je u januaru 2020. godine. Uža naučna oblast gastroenterologija.

Članovi komisije: Prof. dr Dragan Popović i Prof. dr Srđan Đuranović

Mentor: Prof. dr Petar Svorcan

1. Jonaitis L, Marković S, Farkas K, Gheorghe L, Krznarić Ž, Salupere R, et al. .Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective. BMC Proc. 2021 Dec 9;15(Suppl 17):25. (IF 1.57, M22)
2. Markovic S, Jankovic M, Kalaba A, Zogovic B, Sreckovic S.Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series. 2021 Oct 25;13(10):e19019. (IF 1.15, M23)
3. Markovic S, Ivanovski TK, Zogovic B, Kalaba A, Zaric D, Svorcan P. The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy. Inflamm Bowel Dis. Inflamm Bowel Dis. 2021 Mar 9:izab048. doi: 10.1093/ibd/izab048 (IF 5.325, M21)
4. Markovic S, Sreckovic S, Zogovic B, Svorcan P. Postoperative Crohn’s Disease and Relapse Risk Factors: A Single Centre Experience. Acta Scientific Gastrointestinal Disorders. 2021; 4 (3): 19-26. (IF 0,835, M23)
5. Markovic S, Panic N, Zogovic B, Kalaba A, Jankovic M, Knezevic Ivanovski T, Tarabar D, Svorcan P. Short Term Outcome of Saccharomyces boulardii impact the Quality of Life in Patients with Inflammatory Bowel Diseases: A Multicenter, Double Blind, Placebo-Controlled Trial. Acta Scientific Gastrointestinal Disorders. 2021; 4 (3): 27-34 (IF 0,835, M23)
6. Markovic S, Ivanovski TK, Zogovic B, Cvetkovic M, Svorcan P. Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service. Inflamm Bowel Dis. 2020 Nov 19;26(12):e152.. (IF 5.325 M21)
7. Despotović SZ, Milićević NM, Milošević DP, Despotović N, Erceg P, Svorcan P, Schumacher U, Ullrich S, Mihajlović G, Kalem D, Marković S, Lalić IM, Krmpot AJ, Rabasović MD, Pantelić DV, Jovanić SZ, Rösch T, Milićević Ž. Remodeling of extracellular matrix of the lamina propria in the uninvolved human rectal mucosa 10 and 20 cm away from the malignant tumor. Tumour Biol. 2017 Jul;39(7):1010428317711654. (IF 3.048, М21)
8. Protic M, Markovic S, Tarabar D. Case Report: Acute Flair of Ulcerative Colitis during Pregnancy Is Still a Major Problem. Dig Dis. 2017;35(1-2):134-138. doi: 10.1159/000449094. (IF 2.404, М21)
9. Markovic S, Dimitrijevic I, Zogovic B, Markovic V, Barisic G, Krivokapic Z. Current trends in clinical genetics of colorectal cancer. J BUON. 2016 Sept-Oct;21(5):1042-1049. (IF 2.533, М22)
10. Markovic S, Antic J, Dimitrijevic I, Zogovic B, Bojic D, Svorcan P, Markovic V, Krivokapic Z. Microsatellite instability and survival in patients with stage II/III colorectal carcinoma. Indian Journal of Medical Research (IJMR), 2016; 143 (7): 104-111. (IF 2.375, М23)
11. Markovic S, Antic J, Dimitrijevic I, Zogovic B, Bojic D, Svorcan P, Markovic V, Krivokapic Z. Microsatellite instability affecting the T17 repeats in intron 8 of HSP110, as well as five mononucleotide repeats in patients with colorectal carcinoma. Biomark Med. 2013;7(4):613-21. (IF 2.02 М22)
12. Krivokapić Z, Marković S, Antić J, Dimitrijević I, Bojić D, Svorcan P, Jojić N, Damjanović S. Clinical and pathological tools for identifying microsatellite instability in colorectal cancer. Croat Med J. 2012;53(4):328-35. (IF 1.351; М22)
13. Markovic S, Antic J, Dragicevic N, Hamelin R, Krivokapic Z. High-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer. J Mol Histol. 2012;43(2):137-43. (IF 2.531; М22)
14. Bojic D, Markovic S. Terminal ileitis is not always Crohn’s disease. Annals of Gastroenterology.2011; 24: 271-275.
15. Markovic S, Jankovic M, Zaric D, Kalaba A, Vrinic D, Sreckovic S, Svorcan P. Use of Metotrexate in treatment of inflammatory bowel disease. Zvezdara Clin Proc 2018; 19 (1-2): 17-20.
16. Stefanovic K, Gligorijevic G, Jojic B, Vuksanovic M, Janosevic B, Markovic S. Od hiponatremije do hipopituitarizma. Zvezdara Clin Proc 2013; 14 (1-2):20-23.
17. Svorcan P, Markovic S, Bojic B, Djordjevic J, Bojic D, Protic M, Vrinic D, Kazic S, Jojic Nj. Klinicki aspekti portne hipertenzije kod bolesnika sa cirozom jetre. Arch Gastroenterohepatol 2012; 29 (2) 44-50.
18. Bojic D, Markovic S, Bojic B, Maksimovic B, Sreckovic S, Kalem D, Svorcan P, Protic M, Jojic Nj. NSAIL kolopatija: nasi slucajevi i pregled literature. Arch Gastroenterohepatol 2012;29(2):12-17.
19. Bojic D, Maksimovic B, Markovic S, Bojic B, SVorcan P, Jojic Nj. Primarni epiploicni apendagitis kao veoma redak uzrok bola u abdomen –prikaz slucaja. Arch Gastroenterohepatol 2012;29(3):40-43.
20. Maksimovic B, Markovic S, Gligorijevic V, Svorcan P, Jojic N, Bojic D. Moderni fekalni markeri pankreasne i crevne inflamacije –nasa iskustva. Zvezdara Clin Proc 2012;13(1-2):12-15.
21. Svorcan P, Markovic S. Hitna stanja u hepatologiji. Zvezdara Clinic Proceeding 2011; 11(1-2):61-63.
22. Markovic M, Markovic S. Homocistein od fiziologije do kliničke prakse u neurologiji. Apollineum medicum et aesculapium. 2011; 9:1.
23. Svorcan P, Markovic S, Bojic D, Djordjevic J, Vrinic D, Kazic S, Dapcevic B. Klinicke i patofizioloske karakteristike autoimunog pankreatitisa. Internist 2010; 2(1):77-83.
24. Svorcan P, Markovic S, Đorđevic J, Bojić D, Vrinić D, Kažić S, Gligorijevic V, Jojic Nj. Žučne soli i hronične bolesti jetre udružene sa holestazom Zvezdara Clinic Proceeding. 2011; 12 (1-2):32-36.
25. Svorcan P, Markovic S, Djordjevic J, Vrinic D, Bojic D, Kazic S, Jojic Nj. Hepatocelularni karcinom – od epidemiologije do terapije. Internist 2010; 2 (3):141-147.
26. Svorcan P, Markovic S, Bojic D, Protic M, Dapcevic B. Kliničko praćenje i vođenje pacijenata sa cirozom jetre. Internist 2009; 1(2):51-58.
27. Svorcan P, Markovic S, Djordjevic J, Bojic D, Protic M, Dapcevic B. Etioloski i klinicki aspekti akutne i hronicne portne tromboze. Zvezdara Clin Proc 2009; 10 (1-2): 11-18.
28. Svorcan P, Markovic S, Dapčević B. Hiperbilirubinemije. Arch Gastroenterohepatol 2008; 27 (3-4 ): 77 – 88.
29. T Knezevic, M Milic, A Kalaba, S Sreckovic, B Stopic, P Svorcan, S Markovic. Is mucosal healing sufficient paramater for anti-TNF discontinuation? Journal of Crohn’s and Colitis, Volume 14, Issue Supplement_1, January 2020, Pages S433–S434, https://doi.org/10.1093/ecco-jcc/jjz203.626
30. Mitrovic M, Markovic S, Vrinic Kalem D, Jankovic A, Svorcan P. Helicobacter Pylori infection and Nutritional Status in End Stage Renal Disease Patients. UEGW.11-13. Oct 2020.
31. A Kalaba, M Markovic, M Jankovic, D Zaric, S Markovic, P Svorcan. Quality of life of patients with inflammatory bowel diseases in remission on different forms of treatment. Journal of Crohn’s and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S289–S290, https://doi.org/10.1093/ecco-jcc/jjy222.494
32. Markovic S., Kalaba A, Jankovic M, Vrinic D, Zaric D, Svorcan P. Pneumoperitoneum in ulcerative colitis is not always indication for urgent colectomy. European Conference of young Gastroenterologists. Dec. 2018. Zagreb. Croatia.
33. Markovic S., Jankovic M, Kalaba A, Zaric D. Fulminant ulcerative colitis, Clostridium infectiom and anti-TNF rescue therapy. European Conference of young Gastroenterologists. Dec. 2018. Zagreb. Croatia.
34. Knezevic Ivanovski, S. Knezevic Usaj, V. Gligorijevic, Markovic S, P. Svorcan, M. Nedeljkovic Protic Fecal calprotectin as suitable biomarker in evaluation of histological desease Activity, poster presenatacija, dostupno online P236, ECCO 12, Barcelona/Spain, 16-18.02.2017,
35. Markovic S, Krstic M, Antic J, Dimitrijevic I, Markovic V, Svorcan P, Nedeljkovic-Protic M, Krivokapic Z, Microsatellite instability affecting the T17 repeats in intron 8 of HSP110 in patients with colorectal carcinoma. Fit for the Future in Gastroenterology Meeting. EAGEN & EHMSG POSTGRADUATE COURSE 2017, Berlin.
36. Markovic S, Krstic M, Antic J, Dimitrijevic I, Svorcan P, Krivokapic Z, Genetic markers of hereditary colon cancer – important contribution to Lynch syndrome screening in SerbiaFit for the Future in Gastroenterology Meeting. EAGEN & EHMSG POSTGRADUATE COURSE 2016, Berlin
37. Markovic S., Antic J., Dimitrijevic I. Markovic M. Krivokapic Z. Microsatellite instability and hmlh1 promoter gene methylation analysis – important contribution to lynch syndrome screening in serbia. 10th biannual.international symposium of coloproctology October 13 – 15th, 2016. Belgrade, Serbia
38. Markovic S, Krstic M, Antic J, Dimitrijevic I, Svorcan P, Krivokapic Z, hMLH1 promoter gene methylation, BRAF mutation and microsatellite instabilityin colorectal cancer – Serbian cases. Fit for the Future in Gastroenterology Meeting. EAGEN & EHMSG POSTGRADUATE COURSE 2015, Berlin
39. Markovic S. 3 key clinical papers in ’17 on esophagus. Fit for the Future in Gastroenterology Meeting. EAGEN & EHMSG POSTGRADUATE COURSE 2017, Berlin.
40. Gligorijevic V, Bojic D, Markovic S, Maksimovic B, Gligorijevic G, Jojic N. The prevalence of iron deficiency and anemia in an IBD referral center in Serbia Journal of Crohn’s and Colitis.Feb 2014,8(Supplement 1)S116.
41. Markovic S, Antic J, Dimitrijevic I, Markovic V, Krivokapic Z. Correlation of hMLH1 promoter gene methylation and BRAF mutation in colorectal cancer with microsatellite instability8th biannual symposium of coloproctology. Beograd. Oktobar 2014 (oralna prezentacija)
42. Antic J, Markovic S, Krivokapic Z, Damjanovic S. MIcorsatellite instability, T 17 repeats region in intron 8 of HSP110 and BRAF in patients with colorectal carcinoma, ISCO2014 Cancer Genome: From Structure to Function, 11-14 May, 2014, Malaga, Spain.
43. Markovic S, Antic J, Dimitrijevic I, Markovic V, Bojic D, Svorcan P, Jojic Nj, Krivokapic Z. Microsatellite instability and 5-FluoroUracil based chemotherapy in stage II and III colorectal cancer.8th International Congress of the European Federation for Colorectal Cancer (EFR). Acta chirurgica austriaca; 45: (1) Supplement. April 2013
44. Markovic S: How does genetic testing influence management and outcome of colorectal cancer. 10th Congress of the European – African Hepato Pancreato Biliary Association (10th E–AHPBA Congress), May 2013. Belgrade (invited lecture).
45. Markovic S: Genetics of colorectal cancer. XIII National Conference of Coloproctology with International Participation. 27-28 September. 2013. Varna. Bulgaria (invited lecture).
46. Knezevic Ivanovski T, Knezevic Usaj S, Gligorijevic V, Markovic S, Svorcan P, Protic M Fecal calprotectin as suitable biomarker in assesment of histological and endoscopic desease activity, Falk symposia, 30.03.-01.04. Madrid/Spain, poster prezentacija
47. Marković S, Svorcan P, Gligorijević V, Knezevic-Ivanovski T, Srećković S, Nedeljković-Protic M. Risk factors for recurrence of postoperative Crohn’s Disease – single Center experience
48. Gligorijevic V, Knezevic Ivanovski T, Markovic S, Svorcan P, Protic M, Iron deficiency anemia in serbian ibd referral center, Falk symposia, 30.03.-01.04. Madrid/Spain, poster prezentacija
49. Markovic S, Antic J, Dimitrijevic I, Markovic V, Bojic D, Svorcan P, Krivokapic Z. High-frequency microsatellite instability and BRAF mutation (V600E) as prognostic indicators in colorectal cancer. 8th biannual symposium of coloproctology. Beograd. Oktobar 2012 (oralna prezentacija)
50. Bojic B, Markovic S, Sreckovic S, Kalem D, Bojic D, Svorcan P, Protic M, Jojic Nj. Efficacy of Diosmin and band ligation in the treatment of haemorrhoidal disease. 8th biannual symposium of coloproctology. Beograd. Oktobar 2012
51. Markovic S, Antic J, Dimitrijevic I, Markovic V, Bojic D, Svorcan P, Krivokapic Z. Validity of revised Bethesda guidelines for identification microsatellite instability in unselected colorectal cancers in Serbian patients. 8th biannual symposium of coloproctology. Beograd. Oktobar 2012. Treća nagrada.
52. Markovic S, Antic J, Dimitrijevic I, Bojic D, Svorcan P, Jojic Nj, Krivokapic Z: Lymphocytic infiltrate as predictor of microsatellite instability in colorectal cancer? First report from Serbia.7th Internatinal EFR Congress Surgical Congress: Multidisciplinary Tretment of colorectal Cancer. Vienna, Austria , April 28-30, 2011. Eur Surg 2011: 43 (supl 240):11. (Najbolji apstrakt – Ingeborg Hörhager Prize).
53. Markovic S, Antic J, Dimitrijevic I, Markovic V, Bojic D, Svorcan P, Jojic Nj, Damjanovic S, Krivokapic Z: Clinico-pathological features and microsatellite instability in colorectal cancer in Serbian patients. II Kongres gastroenterologa Srbije sa medjunarodnim ucescem. Beograd 30.09.-02.10. 2011. Arch of gastroenterol 2011; 1-2: 65.
54. Markovic S, Dimitrijevic I, Svorcan P, Bojic D, Krivokapic Z: Histological Grade, Lymphocytic Infiltration and Mucin Production as Prognostic Indicators of Colorectal Carcinoma. 4th Congress of the Gastroenterology Association of Bosnia and Herzegovina. Sarajevo 25-28. May 2011.
55. Gligorijevic V, Bojic D, Protic-Nedeljkovic M, Svorcan P, Maksimovic B, Markovic S, Jojic Nj: Epidemiological study of inflammatory bowel disease in single tertiary centre-First report from Serbia. J Crohn Colitis 2011; 5(1); S153 ( P339).
56. Bojic D, Bojic B, Jojic Nj, Svorcan P, Protic M, Markovic S, Maksimovic B, Milosevic D, Ben-Horin S. Tu1419 Ingestion of Inert Colonic Markers As a Novel Method for Predicting the Quality of Preparation for Colonoscopy. Gastrointestinal Endoscopy;73,(4), AB402 – AB403.
57. Knežević Ivanovski T, Marković S, Kalaba A, Srećković S, Vrinić Kalem D, Zarić D, Odanović O, Svorcan P. Kratkoročni rezultati lečenja inflamatornih bolesti creva Vedolizumabom u odnosu na prethodno lečenje antiTNF terapijom. Drugi Kongres Gastroenterologa Srbije, 7-9 Novembra 2019, Knjiga abstrakta
58. Marković S, Jankovic M, Kalaba A, Zarić D, Knežević Ivanovski T, Srećković S, Vrinić Kalem D, Svorcan P. Uticaj nivoa leka Infliksimaba i Adalimumaba na mukozno zaceljenje kod pacijenata sa Kronovom bolesti. Drugi Kongres Gastroenterologa Srbije, 7-9 Novembra 2019, Knjiga abstrakta
59. Marković S, Panić N, Kalaba A, Janković M, Knežević Ivanovski T, Tarabar D, Svorcan P. Multicentrično, placebom kontrolisno ispitivanje kvaliteta života, pacijenata u remisiji Kronove bolesti i ulceroznim kolitisom sa iritabilnim crevnim sindromom lečeni konvencionalnom terapijom uz Bulardi® 500. Drugi Kongres Gastroenterologa Srbije, 7-9 Novembra 2019, Knjiga abstrakta
60. Kalaba A, Markovic M, Jankovic M, Zaric D, Markovic S, Svorcan P. Procena kvaliteta zivota sa inflamatornim bolestima creva na bioloskoj terapiji u odniosu na druge oblike lecenja. Drugi Kongres Gastroenterologa Srbije, 7-9 Novembra 2019, Knjiga abstrakta
61. Kalaba A, Markovic S, Jankovic M, Zaric D, Vrinic D, Sreckovic S, Svorcan P. Severe relapse ofulcerative colitis in patient with dementia: referal IBD unit experience. Drugi Kongres Gastroenterologa Srbije, 7-9 Novembra 2019, Knjiga abstrakta
62. Knežević Ivanovski T, Marković S, Kalaba A, Srećković S, Vrinić Kalem D, Zarić D, Odanović O, Svorcan P. Rezultati ispitivanja efikasnosti i bezbednosti vedlizumaba u lecenju inflamatornih bolesti creva– iskustva referentnog centra. Drugi Kongres Gastroenterologa Srbije, 7-9 Novembra 2019, Knjiga abstrakta
63. Markovic S. Refraktarna celijačna bolest i maligniteti, predavanje po pozivu, Simpozijum o celijakiji, Beograd 2017.
64. Marković S. Antiagregaciona i antikoagulantna terapija u starih iz ugla gastroenterohepatologa XVII Kongres Udruženja internista Srbije, 2017.
65. Markovic S, Dimitrijevic I, Svorcan P, Bojic D, Markovic V, Krivokapic Z. Značaj preoperativne vrednosti serumsog karcinoembrionalnog antigena za pojavu recidiva kod pacijenata sa kolorektalnim karcinomom u II i III stadijumu. XII kongres ucruzenja internista Srbije. Zbornik sažetaka. Vrnjačka Banja. Juni 7-10.2012; 23.
66. Markovic S, Dimitrijevic I, Bojic D,  Svorcan P, Markovic V, Krivokapic Z : Specificnost i senzitivnost tumorskih markera, CEA i Ca 19-9 , za metastatski kolorektalni karcinom. XI kongres udruzenja internista Srbije. Vrnjacka Banja 8-12.06.2011. Knjiga sazetaka str 43 ( P 69 ).
67. Markovic S, Krivokapic Z, Dimitrijevic I, Svorcan P, Bojic D. Klinicki znacaj limfocitne infiltracije u kolorektalnom karcinomu. X kongres udruzenja internista Srbije. Beograd 9-12.06.2010. Knjiga sazetaka str 58 ( P 103 ).
68. Bojic D, Bojic B, Protic M, Svorcan P, Necic D, Markovic S, Jojic Nj. Fekalni kalprotektin u proceni aktivnosti Kronove bolesti: korelacija sa Harvey-Bradshow indeksom, laboratorijskim, endoskopskim i histoloskim nalazima. X kongres udruzenja internista Srbije. Beograd 9-12.06.2010. Oralna prezentacija. Knjiga sazetaka str 21 ( O 036 ).
69. Markovic S: Kako pratiti pacijenta sa dijagnostikovanom inflamatornom bolesti creva ?, IV Kongres Gastroenterologa 2019. Beograd
70. MarkovicS: Како препознати и лечити иритабилни цревни синдром код пацијената са инфламаторном болести црева ? SIBDA, 2018.Beograd
71. Markovic S: Uloga Metotrexata u inflamatornim bolestima creva. SIBDA, 2019.Beograd
72. Markovic S. Refraktarna celijačna bolest i maligniteti, predavanje po pozivu, Simpozijum o celijakiji, Beograd 2017.
73. Markovic S: Genetics of colorectal cancer. XIII National Conference of Coloproctology with International Participation. 27-28 September. 2013. Varna. Bulgaria.
74. Markovic S: How does genetic testing influence management and outcome of colorectal cancer. 10th Congress of the European – African Hepato Pancreato Biliary Association (10th E–AHPBA Congress), May 2013. Belgrade.

Poglavlja u monografiji istaknutog nacionalnog značaja

1. Markovic S. Krivokapic Z. Карцином дебелог црева: наслеђе и породица. 3. Poglavlje- Karcinom debelog creva. I izdanje. SANU. Zavod za udzbenike Beograd. 2018
2. Markovic S, Krivokapic Z. VII poglavlje Hereditarni karcinomi kolona i rektuma. Krivokapic Z. Karcinom rektuma: Poglavlje 7. Hereditarni karcinomi kolona i rektuma. I izdanje. Zavod za udžbenike. Beograd 2012.

Poglavlje u udžbeniku

1. Svorcan P, Markovic S. Urgentna stanja u gastroenterohepatologiji, Urgentna medicina – za studente stomatologije. Stomatološki fakultet Pančevo.2015. 225-241.

Odgovorni urednik i autor monografije IBD u 12 lekcija

Марковић С, Сворцан П. Инфламаторне болести црева у 12 лекција. Марковић С. Прво издање. Клиничко-болнички Центар „Звездара“. Београд 2022.

Kao sekretar gastroenterološke sekcije učestvovao u oganizaciji sastanaka Gastroenterološke sekcije od 2019. godine. Aktivno učestvuje u aktivnostima Srpskog udruženja za inflamatorne bolesti creva i organizaciji stručnih sastanaka Udruženja.

Recezent u nekoliko međunarodnih časopisa od kojih je један  Journal of Molecular Histology, IF 2.531.

Dobitnik je nagrade (Ingeborg Horhager Prize) za najbolji apstrakt i prezentaciju na Evropskom kongresu posvećenom kolorektalnom karcinomu u aprilu 2011. godine u Beču i treće nagrade na Međunardnom koloproktološkom kongresu u Beogradu u decembru 2012.godine

2008-2010: Naziv projekta „ Faktori koji utiču na pojavu lokalnog recidiva, kvalitet života i funkcionalne rezultate kod bolesnika operisanih zbog karcinoma rektuma“. No ON145079, nosilac projekta – prof. dr Zoran Krivokapić.

2011-2014: Naziv projekta „Uloga preoperativnog određivanja stadijuma bolesti, prognostičkih, terapijskih markera, objektiviziranje funkcionalnih rezultata u odluci o strategiji lečenja karcinoma rektuma, a u cilju unapređenja onkoloških